The lung function profile of once-daily tiotropium and olodaterol via Respimat(®) is superior to that of twice-daily salmeterol and fluticasone propionate via Accuhaler(®) (ENERGIT...

por Beeh, Kai-Michael, Derom, Eric, Echave-Sustaeta, José, Grönke, Lars, Hamilton, Alan, Zhai, Dongmei, Bjermer, Leif
Publicado 2016

Comorbidity in chronic obstructive pulmonary disease. Related to disease severity?

por Echave-Sustaeta, Jose M, Comeche Casanova, Lorena, Cosio, Borja G, Soler-Cataluña, Juan Jose, Garcia-Lujan, Ricardo, Ribera, Xavier
Publicado 2014

Inhaler Adherence in COPD: A Crucial Step Towards the Correct Treatment

por Turégano-Yedro, Miguel, Trillo-Calvo, Eva, Navarro i Ros, Fernando, Maya-Viejo, José David, González Villaescusa, Cruz, Echave Sustaeta, Jose Maria, Doña, Esperanza, Alcázar Navarrete, Bernardino
Publicado 2023

Efficacy of FF/UMEC/VI compared with FF/VI and UMEC/VI in patients with COPD: subgroup analysis of the Spain cohort in IMPACT

por Marín, José M., Mateos, Luis, Roldán, Juan, Echave-Sustaeta, José M., Pascual-Guardia, Sergi, Pardo, Maria V., Velasco, Beatriz, Jones, C. Elaine, Kilbride, Sally, Lipson, David A.
Publicado 2020

Characterization of COPD Admissions During the First COVID-19 Outbreak

por Cosio, Borja G, Shafiek, Hanaa, Toledo-Pons, Nuria, Iglesias, Amanda, Barcelo, Margalida, Represas-Represas, Cristina, Comeche, Lorena, Catalan, Pablo, Fernandez-Villar, Alberto, Lopez- Campos, Jose Luis, Echave-Sustaeta, Jose, Soler-Cataluna, Juan Jose
Publicado 2021